Cargando…
Inflammatory Pathways as Promising Targets to Increase Chemotherapy Response in Bladder Cancer
While more and more physicians are choosing chemotherapy for patients with bladder cancer, the current treatment is still far from satisfactory due to low response rate and severe side effects. Emerging evidence indicates that inflammatory microenvironment is involved in the pathogenesis of bladder...
Autores principales: | Zhu, Zhaowei, Shen, Zhoujun, Xu, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395159/ https://www.ncbi.nlm.nih.gov/pubmed/22811589 http://dx.doi.org/10.1155/2012/528690 |
Ejemplares similares
-
Risk of bladder cancer in patients with diabetes mellitus: an updated meta-analysis of 36 observational studies
por: Zhu, Zhaowei, et al.
Publicado: (2013) -
Diabetes Mellitus and Risk of Bladder Cancer: A Meta-Analysis of Cohort Studies
por: Zhu, Zhaowei, et al.
Publicado: (2013) -
MicroRNA-31 functions as a tumor suppressor and increases sensitivity to mitomycin-C in urothelial bladder cancer by targeting integrin α5
por: Xu, Tianyuan, et al.
Publicado: (2016) -
Targeting of CCN2 suppresses tumor progression and improves chemo-sensitivity in urothelial bladder cancer
por: Wang, Xiaojing, et al.
Publicado: (2017) -
CIP2A depletion potentiates the chemosensitivity of cisplatin by inducing increased apoptosis in bladder cancer cells
por: Gao, Fengbin, et al.
Publicado: (2018)